75F40121C00138

STIMULATE INNOVATION IN CLINICAL EVALUATIONS AND PERSONALIZED MEDICINE TO IMPROVE PRODUCT DEVELOPMENT AND PATIENT OUTCOMES.

Food and Drug Administration · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedHealthcare & MedicalFederal

Basic information

Reference number: 75F40121C00138
Issuing organization: Food and Drug Administration · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: STIMULATE INNOVATION IN CLINICAL EVALUATIONS AND PERSONALIZED MEDICINE TO IMPROVE PRODUCT DEVELOPMENT AND PATIENT OUTCOMES.
Source: USASpending (Federal)
Source ID: usa-75F40121C00138

Details

Location: United States

Description

STIMULATE INNOVATION IN CLINICAL EVALUATIONS AND PERSONALIZED MEDICINE TO IMPROVE PRODUCT DEVELOPMENT AND PATIENT OUTCOMES. Awarded to: ACADEMISCH ZIEKENHUIS LEIDEN Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT

Dates

Publication: 2021/09/23 12:00:00 AM UTC
Closing date: 2024/09/29 12:00:00 AM UTC

Estimated value

$1.0M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-05-25, 2:30:08 p.m.

Data refreshed every 2 hours